Emma R. Parmee - Concepedia

Author

Emma R. Parmee

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

E R Parmee, E. R. PARMEE, E. R. Parmee, E.R. Parmee, Emma Parmee, Emma R Parmee, Emma R. Parmee, Emma R. Parmee, Parmee, E.R.

Publications

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Emma R. Parmee is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	30	1.6K
2	Natural Sciences	13	13	728
3	Biochemistry	12	13	781
4	Engineering	7	7	462
5	Health Sciences	5	5	282

Emma R. Parmee

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides Linda Brockunier, Emma R. Parmee, Hyun Ok, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinePharmacological AgentExperimental PharmacologyPharmacotherapy	2000	199
New catalysts for the asymmetric aldol reaction: chiral boranes prepared from .alpha.,.alpha.-disubstituted glycine arenesulfonamides Emma R. Parmee, Orin Tempkin, Satoru Masamune, Journal of the American Chemical Society Chiral BoranesEngineeringBiochemistryNatural SciencesAltmetric Attention Score	1991	179
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer Wonsuk Chang, Michael D. Altman, Charles A. Lesburg, Journal of Medicinal Chemistry ImmunologyMolecular BiologyInterferon GenesImmunotherapyTumor Biology	2022	122
Crystal Structure of Human Phosphodiesterase 3B: Atomic Basis for Substrate and Inhibitor Specificity Giovanna Scapin, Sangita B. Patel, Jeffrey P. Varnerin, Biochemistry Crystal StructureProteinlipid InteractionMolecular BiologyChemical BiologyMetabolic Syndrome	2004	116
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. M. H. FISHER, A Amend, Tom Bach, Journal of Clinical Investigation Metabolic RateObesityMolecular PharmacologyMetabolic SyndromeAdrenal Gland	1998	115
The catalytic asymmetric aldol reaction of aldehydes with unsubstituted and monosubstituted silyl ketene acetals: formation of anti-β-hydroxy-α-methyl esters Emma R. Parmee, Yaping Hong, Orin Tempkin, Tetrahedron Letters EngineeringOrganic ChemistryCatalysisAnti-β-hydroxy-α-methyl EstersSilyl Ketene Acetals	1992	109
Palladium-Catalyzed Coupling of Vinylogous Amides with Aryl Halides: Applications to the Synthesis of Heterocycles Scott D. Edmondson, Anthony Mastracchio, Emma R. Parmee Organic Letters Palladium-catalyzed CouplingChemical EngineeringVinylogous AmidesAryl HalidesAryl Component	2000	102
Substituted piperazines as novel dipeptidyl peptidase IV inhibitors Linda Brockunier, Jiafang He, Lawrence F. Colwell, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryMedicinePharmacological AgentPharmacotherapy	2004	97
Discovery of a Novel Glucagon Receptor Antagonist<i>N</i>-[(4-{(1<i>S</i>)-1-[3-(3, 5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1<i>H</i>-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the Treatment of Type II Diabetes Yusheng Xiong, Jian Guo, Mari R. Candelore, Journal of Medicinal Chemistry	2012	86
Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors Jinyou Xu, Hyun Ok, Edward J. Gonzalez, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2004	76

Page 1